Prescription Diet Pills: Options, Eligibility, Safety, and How They Compare

Prescription diet pills are medications a licensed clinician may prescribe for adults with obesity or some adults with overweight and weight-related conditions. Options include phentermine, phentermine-topiramate, naltrexone-bupropion, orlistat, and newer oral GLP-1 medicines. The right choice depends on BMI, health history, contraindications, side effects, goals, cost, and clinical follow-up 1.

What are prescription diet pills?

Prescription diet pills are regulated medicines used for weight management under clinician care. They are different from over-the-counter supplements because they have FDA labeling, known contraindications, and safety warnings that a clinician must review 1.

Prescription weight loss pills are not the same as supplements

A prescription weight management medication is evaluated as a drug, with a labeled active ingredient, dosing framework, warnings, and known drug interactions. Many supplements are sold without the same level of evidence, and they should not be treated as substitutes for prescription care 1.

Most are used with nutrition, activity, and behavior support

The National Institute of Diabetes and Digestive and Kidney Diseases says prescription medicines for overweight and obesity are used along with a reduced-calorie eating plan and physical activity, not instead of them 1. This matters because weight maintenance often depends on long-term habits, follow-up, and a plan for side effects.

Eligibility is usually based on BMI and weight-related health risks

Clinicians often use BMI 30 or greater as one starting point for obesity medication eligibility, or BMI 27 or greater when a person also has a weight-related condition such as type 2 diabetes, hypertension, high cholesterol, or sleep apnea 1. BMI is only a screening tool, so the final decision also depends on medical history and medication safety.

Who may qualify for prescription weight loss medication?

Prescription weight loss medication may be considered for adults with obesity, or for adults with overweight and a related health condition. A clinician still has to review pregnancy status, blood pressure, heart history, mood history, seizure risk, eye history, pancreas or gallbladder history, and current medicines 1.

• BMI 30 or greater is a common threshold used in obesity medication guidance 1.
• BMI 27 or greater plus a weight-related condition is another common threshold 1.
• Weight-related conditions may include type 2 diabetes, hypertension, high cholesterol, sleep apnea, and other risks a clinician documents.
• Some patients with PCOS also seek weight management care because insulin resistance and weight can interact, but medication choice still requires individualized review.

Pregnancy is a key safety issue. For example, phentermine-topiramate can cause fetal harm and has strict pregnancy-related labeling, while several GLP-1 labels advise stopping before a planned pregnancy because of potential fetal risk 3, 7.

What pills do doctors prescribe for weight loss?

Doctors may prescribe several oral anti-obesity medications, including phentermine, phentermine-topiramate, naltrexone-bupropion, and orlistat. Newer oral GLP-1 options are also being studied, while injectable GLP-1 and dual GIP/GLP-1 medicines remain important options for many patients 1.

Phentermine, including Adipex-P, for short-term appetite suppression

Phentermine, sold under brand names including Adipex-P, is a sympathomimetic appetite suppressant. FDA labeling describes it as a short-term adjunct for weight reduction in patients with an initial BMI of 30 or greater, or 27 or greater with risk factors, when used with diet and exercise 2.

Because phentermine can raise heart rate or blood pressure and has stimulant-like effects, clinicians may avoid it in people with certain cardiovascular disease, uncontrolled hypertension, hyperthyroidism, glaucoma, agitation, or recent monoamine oxidase inhibitor use 2. Common side effects can include dry mouth, insomnia, restlessness, and palpitations 2.

Phentermine-topiramate, brand name Qsymia

Phentermine-topiramate, brand name Qsymia, combines an appetite suppressant with topiramate, an anticonvulsant that can affect appetite and cravings. In FDA labeling, Qsymia is indicated as an adjunct to reduced-calorie diet and increased physical activity for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity 3.

Key cautions include pregnancy risk, increased heart rate, mood changes, cognitive effects, glaucoma, metabolic acidosis, kidney stones, and possible suicidal thoughts or behavior warnings related to antiepileptic drugs 3. Common side effects include tingling, dizziness, altered taste, insomnia, constipation, and dry mouth 3.

Naltrexone-bupropion, brand name Contrave

Naltrexone-bupropion, brand name Contrave, combines an opioid antagonist with bupropion, an antidepressant that also affects appetite pathways. Its FDA labeling states it is used with a reduced-calorie diet and increased physical activity for chronic weight management in adults with obesity or overweight with at least one weight-related condition 4.

Contrave is not a fit for everyone. The label lists contraindications including uncontrolled hypertension, seizure disorder, bulimia or anorexia nervosa, chronic opioid use, abrupt discontinuation of alcohol or certain sedatives, and use of other bupropion-containing products 4. Common side effects include nausea, constipation, headache, vomiting, dizziness, insomnia, dry mouth, and diarrhea 4.

Orlistat, brand names Xenical and Alli

Orlistat, brand names Xenical and Alli, is a lipase inhibitor. It works in the gut by reducing absorption of some dietary fat, which means it does not act on the brain’s appetite centers 5.

Because orlistat changes fat absorption, side effects are often gastrointestinal. The Xenical label lists oily spotting, gas with discharge, urgent bowel movements, fatty or oily stool, increased defecation, and fecal incontinence among common effects 5. It can also reduce absorption of fat-soluble vitamins, so clinicians review nutrition and medication timing 5.

Oral GLP-1 options such as semaglutide and orforglipron

Rybelsus is oral semaglutide, a GLP-1 receptor agonist approved for type 2 diabetes, not chronic weight management. Wegovy is semaglutide 2.4 mg injection, a GLP-1 receptor agonist approved for chronic weight management in certain patients 6.

Orforglipron is an oral, non-peptide GLP-1 receptor agonist that has been studied for obesity, including in a phase 2 trial published in the New England Journal of Medicine in 2023 10. As with other GLP-1 drugs, gastrointestinal side effects such as nausea, vomiting, diarrhea, and constipation are important to review 10.

How do prescription diet pills work?

Prescription diet pills work through different pathways, so one medicine may feel very different from another. Some affect appetite signals, some reduce fat absorption, and GLP-1 or GIP/GLP-1 medicines affect gut-brain hormone pathways tied to hunger, fullness, and delayed gastric emptying 1.

• Appetite suppression and fullness signals: Phentermine and phentermine-topiramate can reduce appetite, but stimulant-like effects and heart rate changes can limit use 2, 3.
• Reward and craving pathways: Naltrexone-bupropion affects brain pathways involved in appetite and reward, but it carries seizure, blood pressure, opioid-use, and mood-related warnings 4.
• Fat absorption blocking: Orlistat reduces absorption of some dietary fat, but this can cause oily stools and lower fat-soluble vitamin absorption 5.
• GLP-1 and GIP hormone pathways: Semaglutide is a GLP-1 receptor agonist, while tirzepatide is a dual GIP/GLP-1 receptor agonist; both can increase fullness and slow gastric emptying, but nausea, vomiting, diarrhea, constipation, gallbladder issues, and pancreatitis warnings matter 6, 7.

Mechanism matters because side effects often follow the pathway. A medicine that affects norepinephrine may be a poor fit for uncontrolled blood pressure, while a medicine that slows gastric emptying may be hard for someone with severe gastrointestinal disease 2, 6.

Which prescription diet pill is most effective?

There is no single “best” prescription diet pill for everyone. In clinical trials, average weight loss varies by active ingredient, dose studied, follow-up time, starting weight, adherence, and side effects, and individual results vary 8, 9.

In the STEP 1 trial, adults without diabetes received once-weekly semaglutide 2.4 mg plus lifestyle intervention for 68 weeks; the semaglutide group lost an average 14.9% of body weight versus 2.4% with placebo 8. That result applies to the active ingredient as studied in the trial, not to compounded formulations, which are not FDA-approved and do not have FDA-evaluated outcomes data.

In the SURMOUNT-1 trial, adults with obesity or overweight without diabetes received tirzepatide 5 mg, 10 mg, or 15 mg once weekly for 72 weeks; mean weight reduction was 15.0%, 19.5%, and 20.9%, compared with 3.1% with placebo 9. Tirzepatide’s FDA label also includes warnings and contraindications, including a boxed warning about thyroid C-cell tumors and contraindication in people with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 7.

Older oral medicines can still be useful for some patients, but “strongest” does not always mean “best.” A clinician may choose a less potent average option if it better fits blood pressure, mood history, pregnancy plans, gastrointestinal tolerance, access, or cost.

Prescription diet pills compared

Prescription diet pills differ in form, mechanism, duration, and safety profile. This table gives a practical overview, but it cannot replace a clinician’s review of your health history and current medicines.

Pills can feel simpler because there is no injection, but they may have timing rules, stimulant effects, or gut side effects. Injections are usually less frequent and, for GLP-1 and dual GIP/GLP-1 medicines, have strong trial evidence for average weight loss, but they require comfort with injections and careful side-effect monitoring 6, 7, 8, 9.

Is phentermine better than Ozempic or GLP-1 medications?

Phentermine and GLP-1 medications are not the same type of treatment. Phentermine is a short-term sympathomimetic appetite suppressant, while semaglutide and tirzepatide work through hormone pathways that affect fullness, food intake, and gastric emptying 2, 6, 7.

Ozempic is semaglutide approved for type 2 diabetes, while Wegovy is semaglutide approved for chronic weight management in certain patients. Mounjaro is tirzepatide approved for type 2 diabetes, while Zepbound is tirzepatide approved for chronic weight management and certain adults with obstructive sleep apnea and obesity 6, 7.

A clinician may avoid stimulant-like medicines such as phentermine when a patient has uncontrolled blood pressure, certain heart conditions, hyperthyroidism, glaucoma, or high risk from insomnia or agitation 2. A clinician may avoid GLP-1 or dual GIP/GLP-1 medicines when there is a contraindication such as personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, and will also review pancreas, gallbladder, kidney, and gastrointestinal history 6, 7.

Can you lose 20 pounds on prescription diet pills?

Twenty pounds means different things depending on starting weight. Clinicians often track percent body weight lost because 20 pounds is 10% of body weight for someone starting at 200 pounds, but about 6.7% for someone starting at 300 pounds.

Trial averages show that some active ingredients can produce that scale of loss for some participants, but no medication guarantees it. In STEP 1, semaglutide 2.4 mg led to 14.9% mean body weight loss at 68 weeks, and in SURMOUNT-1 tirzepatide 10 mg and 15 mg led to 19.5% and 20.9% mean body weight loss at 72 weeks; individual results vary 8, 9.

Weight regain can happen after stopping medication. In a STEP 1 extension, participants regained about two-thirds of their prior weight loss during the year after semaglutide withdrawal, which supports the idea that obesity is often a chronic condition needing a long-term plan 12.

How do you get prescription weight loss medication online safely?

Online prescription weight loss care should still feel like medical care. A legitimate telehealth visit should review BMI, medical history, current medicines, pregnancy status, contraindications, side effects, goals, and follow-up—not just take payment and ship a product.

• Look for licensed clinician review before any prescription is written.
• Avoid sites that promise approval, guarantee a certain number of pounds lost, or sell “prescription-strength” supplements without a prescription.
• For compounded medications, look for state-licensed 503A pharmacy fulfillment and clear ingredient, concentration, and safety information.
• Ongoing follow-up matters because nausea, constipation, blood pressure, mood symptoms, dose changes, and medication interactions may need clinician input.

The main safety line is licensed care versus unlicensed access. A licensed provider and a state-licensed 503A pharmacy create accountability that no-prescription “research chemical” or supplement sellers do not provide.

Prescription weight loss treatment at Chia: tablets, injections, and clinician-guided care

At Chia, we offer compounded GLP-1 weight loss treatment through an online medical visit, licensed US provider review, and state-licensed 503A pharmacy fulfillment. Our current GLP-1 options are compounded tirzepatide, available as tablets or injections, and compounded semaglutide, available as injections.

Chia’s GLP-1 care starts with a short health questionnaire. A licensed US provider reviews the intake and prescribes only when clinically appropriate; a prescription is never guaranteed. If prescribed, medication is compounded in the US by a state-licensed 503A pharmacy and shipped to the patient’s door.

Dosing is provider-guided and adjusted over time, including microdosing plans for tirzepatide and semaglutide when clinically appropriate. Patients can message their care team through the patient portal between visits.

Compounded tirzepatide and compounded semaglutide are not FDA-approved, and FDA-approved brand-name drugs should not be described as interchangeable with compounded versions. Results are not established for compounded formulations in the same way they are for FDA-approved products studied in large trials.

What side effects and risks should patients ask about?

Side effects and contraindications are part of choosing any anti-obesity medication. Benefits should never be weighed without the risks, because the best medication is the one that fits both your goals and your health history.

• GLP-1 medicines: nausea, vomiting, diarrhea, constipation, abdominal pain, delayed gastric emptying, gallbladder disease, pancreatitis warnings, kidney injury risk with dehydration, and thyroid C-cell tumor warnings on some labels 6, 7.
• Phentermine-containing medicines: insomnia, dry mouth, palpitations, increased heart rate, blood pressure concerns, glaucoma, hyperthyroidism, and pregnancy concerns for phentermine-topiramate 2, 3.
• Naltrexone-bupropion: nausea, constipation, headache, seizure risk, blood pressure concerns, opioid-use contraindications, and suicidal thoughts warning 4.
• Orlistat: oily stools, gas with discharge, urgent bowel movements, and fat-soluble vitamin absorption issues 5.

Compounded medications require extra transparency. Patients should know the active ingredient, dosage form, pharmacy source, how to contact the care team, what side effects to report, and how follow-up works.

What should you ask a clinician before starting?

A clinician visit should help match the medication to the person, not just the diagnosis. Bring a complete medication list, your weight history, pregnancy plans if relevant, and any history of high blood pressure, mood symptoms, seizure, glaucoma, pancreatitis, gallbladder disease, thyroid cancer, or eating disorder.

1. 1Which options fit my BMI, health history, and current medications?
2. 2Which side effects should I watch for, and when should I contact the care team?
3. 3How will progress, side effects, and dose changes be monitored?
4. 4What are my options if cost, access, or tolerability becomes a problem?
5. 5What happens if I stop the medication or need to pause it for surgery, pregnancy planning, or side effects?

FAQ

Keep reading

Weight Loss

How to Get Weight Loss Medication: Eligibility, Options, and Costs

Weight Loss Medication

How to Get Weight Loss Drugs: A Step-by-Step Patient Guide

Weight Loss

GLP-1 Shots Online: Prescription, Cost, Safety, and Delivery